Skip to main content

Walleye Capital LLC

Position in JANX — Janux Therapeutics, Inc.

CIK 1758720 NEW YORK, NY

Position in JANX

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$1,815,590
-$2,642,044 QoQ
Shares Held
130,618
-59.6% QoQ
Ownership
0.214%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2024
6 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in JANX Over Time

Shares Held

Position Value (USD)

Derivatives in JANX

reported options exposure · as of Mar 31, 2026
CallValue
$606,040
CallShares
43,600
PutValue
$58,380
PutShares
4,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Walleye Capital LLC holds $278,334,962 across 104 Biotechnology names. JANX ranks #39 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in JANX

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $606,040 43,600
2026-03-31 $1,815,590 130,618
2026-03-31 $58,380 4,200
2025-12-31 $55,200 4,000
2025-12-31 $4,457,634 323,017
2025-12-31 $149,040 10,800
2025-09-30 $875,465 35,821
2025-06-30 $13,860 600
2025-06-30 $1,235,295 53,476
2025-03-31 $307,260 11,380
2024-06-30 $603,174 14,399
2024-06-30 $113,103 2,700
2024-06-30 $121,481 2,900